FreeOx Biotech
PrivateLast Round
Crowdfunding
Jan 31, 2026
Est. Valuation
$20.6M
Total Funding Raised
$5.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
FreeOx Biotech operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Crowdfunding round in January 2026.
FreeOx Biotech is a biotechnology company that develops cerebrovascular protective therapies designed to reduce the effects of oxidative stress related to the neurological and cardiovascular systems.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
FreeOx Biotech Comparables
Compare FreeOx Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| aptaTargets | 88% | |
| NoNO Inc. | 84% | |
| Argenica Therapeutics | 79% |
For institutional investors. Book with your work email.
FreeOx Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jan 31, 2026 | ||||
| Seed | Dec 5, 2023 | ||||
| Angel | Nov 8, 2018 | ||||
| Grant | Aug 9, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
FreeOx Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EIT Health | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 50% MoM.
- Jan 31, 2026
Raised $3M led by Neurotechnology Investors.
For institutional investors. Book with your work email.
FreeOx Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about FreeOx Biotech's valuation, stock price, and market status.
Is FreeOx Biotech a public or private company?
FreeOx Biotech is a private company.
What is the current stock price of FreeOx Biotech?
FreeOx Biotech is a private company, so its shares have no public market price. Caplight tracks FreeOx Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is FreeOx Biotech worth (valuation)?
FreeOx Biotech's valuation is estimated at $20.6M based on funding round data.
Can I buy FreeOx Biotech stock?
FreeOx Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was FreeOx Biotech's last funding round?
FreeOx Biotech's most recent funding round was Crowdfunding on January 31, 2026.
Who are the main investors in FreeOx Biotech?
Key investors in FreeOx Biotech include EIT Health.
Will FreeOx Biotech IPO soon?
No public IPO plans have been announced for FreeOx Biotech.
How can I track FreeOx Biotech secondary market activity?
Caplight tracks bids, offers, and trades in FreeOx Biotech's shares on secondary markets.